Immunosyn Corporation - Securities Class Action

Company and Case Information

IMPORTANT INFORMATION | INDEX OF FILINGS | SEARCH

Home

Index of Filings

News and Press Releases

Filings

Decisions

Settlements

Litigation Activity Indices

Top Ten List

Annual/Quarterly Updates

Clearinghouse Research

Articles & Papers

Search

Related Sites

About Us

Local Rules

Sponsors

Register

_______________
Copyright (c) 2001
Stanford Law School

Immunosyn Corporation Summary: Immunosyn Corporation (Immunosyn) is a development stage company. The Company owns a worldwide license to market, distribute and sell a biopharmaceutical drug product, referred to as SF-1019, for multiple uses, including the treatment of any and all diseases, and pathological conditions. Under the terms of its license, the Company is further granted the rights to any improvement of SF-1019 and other compounds, which are developed under the same technology platform, and which are chemically similar to SF-1019.

According to the complaint filed August 24, 2009, the Defendants are in violation of 15 U.S.C. § 78r and/or 17 C.F.R. §240.10b-5 by making false and/or misleading statements concerning Immunyson and SF-1019 in SEC filings, including but not limited to: a) failing to report income generated from the sale of SF-1019, b) claiming in al O-QSB for the period ending 9/30/07 that Immunyson had the "exclusive worldwide license to market, distribute and sell . . . SF-1019," c) failing to timely report in its SEC filings a lawsuit brought by Salvatore and Frank Bramante against Immunyson, d) claiming that Argyll Biotech's only data regarding the safety and efficacy of SF-1019 is based on uncontrolled observations of a precursor to SF-1019 among a small group of individuals, not SF-1019 itself, e) failing to disclose that SF-1019 was on clinical hold, d) misrepresenting the approvals obtained for SF-1019, 0 failing to disclose that SF-1019 was being sold through channels outside of Immunyson, g) failing to disclose the business relationship between Alan Osmond and Immunyson and/or Argyll Biotech, and h) selling a water/saline solution/and/or product without active agents as SF-1019.

On October 24, 2009, the defendants filed a motion to dismiss. Another motion to dismiss was filed on February 24, 2010. The motions were granted in part and denied in part on August 31, 2010. The plaintiffs were given leave to amend, and on September 30, 2010, a First Amended Complaint was filed. The defendants filed a motion to dismiss on October 14 and 26, 2010. The plaintiffs were granted leave to file an amended complaint, and did so on December 14, 2010. The motion to dismiss was denied on January 18, 2011. The parties are now engaging in discovery proceedings.

INDUSTRY CLASSIFICATION:
SIC Code: 2836
Sector: Healthcare
Industry: Biotechnology & Drugs

COMPANY/ISSUER NAME:	Immunosyn Corporation
COMPANY/ISSUER TICKER:	IMYN
COMPANY WEBSITE:	http://www.immunosyn.com

FIRST IDENTIFIED COMPLAINT IN THE DATABASE

Denise Campbell, et al. v. Immunosyn Corporation, et al.

COURT: S.D. Texas	DOCKET NUMBER: 09-CV-00197
JUDGE NAME: Hon. Andrew S. Hanen
DATE FILED: 08/24/2009	SOURCE:
CLASS PERIOD START: 01/10/2008	CLASS PERIOD END: 08/24/2009
TYPE OF COMPLAINT: Complaint (Unamended and Unconsolidated)
PLAINTIFF FIRMS NAMED IN COMPLAINT:
Gershon D. Cohen 1777 N.E. Loop 410, Suite 600, San Antonio, TX, 78217 (voice) 210.826.7299, (fax) 210.826.7299, Law Offices of Andrew J. Tine 251 Thames Street, 2nd Floor, Bristol, RI, 02809 (voice) 401.396.9002, (fax) 401.396.9002, _____________________________________________ TOTAL NUMBER OF PLAINTIFF FIRMS: 2

DOCUMENTS FOR THE FIRST IDENTIFIED COMPLAINT
Class Action Complaint And Jury Demand
Type: Complaint		Date on the document: 08/24/2009
Order On Motions To Dismiss
Type: Order		Date on the document: 08/31/2010

REFERENCE COMPLAINT

Denise Campbell, et al. v. Immunosyn Corporation, et al.

COURT: S.D. Texas	DOCKET NUMBER: 09-CV-00197
JUDGE NAME: Hon. Andrew S. Hanen
DATE FILED: 12/14/2010	SOURCE:
CLASS PERIOD START: 01/10/2008	CLASS PERIOD END: 08/24/2009
TYPE OF COMPLAINT: Second Amended
PLAINTIFF FIRMS NAMED IN COMPLAINT:
Gershon D. Cohen 1777 N.E. Loop 410, Suite 600, San Antonio, TX, 78217 (voice) 210.826.7299, (fax) 210.826.7299, Law Offices of Andrew J. Tine 251 Thames Street, 2nd Floor, Bristol, RI, 02809 (voice) 401.396.9002, (fax) 401.396.9002, _____________________________________________ TOTAL NUMBER OF PLAINTIFF FIRMS: 2

DOCUMENTS FOR THE REFERENCE COMPLAINT
First Amended Complaint And Jury Demand And Proposed Class Action Complaint
Type: Complaint		Date on the document: 09/30/2010
First Amended Complaint And Jury Demand And Proposed Class Action Complaint
Type: Complaint		Date on the document: 12/14/2010
U.S. District Court Civil Docket
Type: Docket		Date on the document: 01/18/2011
U.S. District Court Civil Docket
Type: Docket		Date on the document: 08/14/2011

OTHER DOCUMENTS

Case Name and/or Number:
Type:		Date on the document:

WARNING AND DISCLAIMER OF LIABILITY:
The information included on this Web site, whether provided by personnel employed by Stanford Law School or by third parties, is provided for research and teaching purposes only. Neither Stanford University, Stanford Law School, nor any of their employees, agents, contractors, or affiliates warrant the accuracy or completeness of the information or analyses displayed herein, and we caution all readers that inclusion of any information on this site does not constitute an endorsement of the truthfulness or accuracy of that information. In particular, this Web site contains complaints and other documents filed in federal and state courts, which make allegations that may or may not be accurate. No reader should, on the basis of information contained in or referenced by this Web site, assume that any of these allegations are truthful.

Go to Search page | Go to Case Index page | Back to Top

�